Search | JOV | ARVO Journals

Showing 1 – 20 of 454

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Duration of hyaluronic acid (HA)-induced restoration of accommodation response in presbyopic monkeys

Mary Ann Bernadette Croft; T Michael Nork; Jared McDonald; Alexander Katz; Paul L Kaufman

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):5370.

ARVO Annual Meeting Abstract June 2025

Global Prevalence and Incidence of Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma: A Systematic Review and Meta-analysis

Amirhossein Roshanshad; Zahra Rahimian; Romina Roshanshad; Mohammadreza Akbari; Zahra Amirsardari; Paul L Kaufman; Hossein Molavi Vardanjani

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):1645.

ARVO Annual Meeting Abstract June 2025

Predicting More than Mild Retinopathy in Diabetic Patients Using Patient-Reported Data

Mohamed Ashraf; Amira Mostafa Mostafa; Bassma Al-Bayoumy; Enas Khamis; Heba Abdelaziz; Merna Mostafa; Mohammed Ghonneem; Mostafa Elmanhaly; Nadine Khalid; Ahmed Souka; Paolo S Silva; Jennifer K Sun; Lloyd Paul Aiello

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):3841.

ARVO Annual Meeting Abstract June 2025

Bridging Gaps in Diabetic Retinopathy Care with Locally Developed AI Technology

Cameron Mehran Ashrafzadeh; Milan Bahi; Amira Mostafa Mostafa; Bassma Al-Bayoumy; Enas Khamis; Heba Abdelaziz; Merna Mostafa; Mohammed Ghonneem; Mostafa Elmanhaly; Nadine Khalid; Ahmed Souka; Jennifer K Sun; Paolo S Silva; Lloyd Paul Aiello; Mohamed Ashraf

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4185.

ARVO Annual Meeting Abstract June 2025

Distinctive choroidal vascular hyperpermeability patterns in central serous chorioretinopathy correlate with retinal sensitivity levels on microperimetry

Jennifer Minjia Chang-Wolf; Laurenz JB Pauleikhoff; Chabelie Ruiters; Annette Moll; Reinier Schlingemann; Elon van Dijk; Roselie M.H. Diederen; Camiel J.F. Boon

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):1096.

ARVO Annual Meeting Abstract June 2025

Patients' views on climate change, health and sustainability

Denise Yang-Seeger; Annkathrin Schellstede; Laurenz JB Pauleikhoff; Martin S. Spitzer; Johannes Birtel

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2057.

ARVO Annual Meeting Abstract June 2025

Travel – associated emissions of intravitreal injections

Johannes Birtel; Annkathrin Schellstede; Laurenz JB Pauleikhoff; Martin S. Spitzer; Denise Yang-Seeger

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4119.

ARVO Annual Meeting Abstract June 2025

Sustained suppression of aqueous humor free vascular endothelial growth factor following continuous delivery via the Port Delivery System with ranibizumab in the Pagoda and Pavilion trials

Katie F Maass; Manjot K Gill; Golnaz Javey; Michael Chang; Joy C Hsu; Suk-Joon Hyung; Paul Latkany; Kailin Tian

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2402.

ARVO Annual Meeting Abstract June 2025

Real-world light characterization with applications for myopia management

Coralie Barrau; Camille Prince; Emmanuel Kobia-Acquah; Paul Lynch; Des Coughlan; Daragh Comiskey; Joshua Hazle

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2110.

ARVO Annual Meeting Abstract June 2025

Association between Nicotine and Cannabis Use and Ocular Inflammatory Diseases and Complications: Results from the TriNetX Database

Courtney Oliver; Paulina Liberman; Meghan Berkenstock

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2872.

ARVO Annual Meeting Abstract June 2025

Prospect for timely myopia detection using smartphone photorefraction

Ling Yau Kiu; Wing-yu Tam; Yui-yi Wong; Oi-lam Kwok; Ho-cheung Leung; MK Michael Cheung; Eugene Fu; Paul H Lee; Hong-va Leong; Grace Ngai; Lily YL Chan; Chi-wai Do

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):5232.

ARVO Annual Meeting Abstract June 2025

Pediatric Eyelid Lacerations Presenting to the Emergency Department of a Level 1 Trauma Center

Nishay V Bhatnagar; Ishani Patel; Patrick Hughes; Neelakshi Bhagat; Paul D Langer

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):6160.

ARVO Annual Meeting Abstract June 2025

Safety and Tolerability of RPE Stem Cell-derived RPE (RPESC-RPE) Implantation in Patients with Dry Age-related Macular Degeneration (AMD): Early Low Dose Clinical Outcomes

Jeffrey Stern; Rajesh Rao; Brigitte Arduini; Shuna Park; Glenna Ford; Paul P Lee; Susan Borden; Charles William Ryan; Dhruv Sareen; Clive Svendsen; Keith Wolsieffer; Sally Temple

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2701.

ARVO Annual Meeting Abstract June 2025

Validation of a 3D printed smartphone-based lensmeter enhanced by AI for lens power measurements

Hing Yi Li; Xinwei Zhai; Sidney WF Wong; Andy CF Ngan; Paul H Lee; Eugene Fu; Lily YL Chan; Chi-wai Do

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):3914.

Perspective December 2024

Consensus Recommendations for Studies of Outflow Facility and Intraocular Pressure Regulation Using Ex Vivo Perfusion Approaches

PDF

Ted S. Acott; Michael P. Fautsch; Weiming Mao; C. Ross Ethier; Alex S. Huang; Mary J. Kelley; Mini Aga; Sanjoy K. Bhattacharya; Terete Borras; Diane Bovenkamp; Uttio Roy Chowdhury; Abbot F. Clark; Mohammed I. Dibas; Yiqin Du; Michael H. Elliott; Jennifer A. Faralli; Haiyan Gong; Samuel Herberg; Murray A. Johnstone; Paul L. Kaufman; Kate E. Keller; Ruth A. Kelly; David Krizaj; Markus H. Kuehn; Hoi Lam Li; Raquel Lieberman; Shan C. Lin; Yutao Liu; Fiona S. McDonnell; Colleen M. McDowell; Gillian J. McLellan; Philip Mzyk; Kayarat Saidas Nair; Darryl R. Overby; Donna M. Peters; VijayKrishna Raghunathan; Ponugoti Vasantha Rao; Gavin W. Roddy; Najam A. Sharif; Myoung Sup Shim; Yang Sun; Benjamin R. Thomson; Carol B. Toris; Colin E. Willoughby; Hao F. Zhang; Thomas F. Freddo; Rudolf Fuchshofer; Kamisha R. Hill; Alireza Karimi; Krishnakumar Kizhatil; Casey C. Kopcyznski; Paloma Liton; Gaurang Patel; Michael Peng; Padmanabhan P. Pattabiraman; Ganesh Prasanna; Ester Reina-Torres; E. Griffen Samples; John R. Samples; Cynthia L. Steel; Clemens A. Strohmaier; Preeti Subramanian; Chenna Kesavulu Sugali; Joseph van Batenburg-Sherwood; Cydney Wong; Hannah Youngblood; Gulab S. Zode; Elizabeth White; W. Daniel Stamer
TAGS: body tissue, eye, fluid flow, intraocular pressure, perfusion, regulation, organ culture techniques
Invest. Ophthalmol. Vis. Sci.. 2024; 65(14):32. https://doi.org/10.1167/iovs.65.14.32

ARVO Imaging in the Eye Conference Abstract July 2024

Innovative imaging techniques to study the entire accommodative apparatus; discovering new accommodative phenomena; testing presbyopia interventions.

Mary Ann Croft; T Michael Nork; Jared P. McDonald; Alex Katz; Paul L. Kaufman

Invest. Ophthalmol. Vis. Sci.. 2024; 65(9):PB0093.

ARVO Annual Meeting Abstract June 2024

Restoration of accommodation by hyaluronic acid (HA) injection

Mary Ann Croft; T Michael Nork; Jared P. McDonald; Alexander Katz; Paul L Kaufman

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6316.

ARVO Annual Meeting Abstract June 2024

Evaporative Heavy Liquids for Retinal Tamponade

Avnish Deobhakta; Richard B Rosen; Paul Lee; Harriet Lloyd

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):887.

ARVO Annual Meeting Abstract June 2024

Port Delivery System With Ranibizumab (PDS) in diabetic macular edema (DME): additional primary analysis results of the phase 3 Pagoda trial

Varun Malhotra; Michael A. Klufas; Dennis M Marcus; Jordan M Graff; Peter A Campochiaro; Salman Rahman; Paul Latkany; Shamika Gune; Stephanie DeGraaf; Ashwini Bobbala; Mel Rabena; Carlos Ruiz; Arshad M. Khanani

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6233.

ARVO Annual Meeting Abstract June 2024

Port Delivery System with ranibizumab (PDS) stabilizes retinal nonperfusion and macular leakage: results from Pagoda and Pavilion phase 3 trials in diabetic macular edema (DME) and diabetic retinopathy (DR)

Robert Wirthlin; Manjot Gill; Dena Howard; Alicia Menezes; Salman Rahman; Paul Latkany

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6232.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Duration of hyaluronic acid (HA)-induced restoration of accommodation response in presbyopic monkeys

Global Prevalence and Incidence of Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma: A Systematic Review and Meta-analysis

Predicting More than Mild Retinopathy in Diabetic Patients Using Patient-Reported Data

Bridging Gaps in Diabetic Retinopathy Care with Locally Developed AI Technology

Distinctive choroidal vascular hyperpermeability patterns in central serous chorioretinopathy correlate with retinal sensitivity levels on microperimetry

Patients' views on climate change, health and sustainability

Travel – associated emissions of intravitreal injections

Sustained suppression of aqueous humor free vascular endothelial growth factor following continuous delivery via the Port Delivery System with ranibizumab in the Pagoda and Pavilion trials

Real-world light characterization with applications for myopia management

Association between Nicotine and Cannabis Use and Ocular Inflammatory Diseases and Complications: Results from the TriNetX Database

Prospect for timely myopia detection using smartphone photorefraction

Pediatric Eyelid Lacerations Presenting to the Emergency Department of a Level 1 Trauma Center

Safety and Tolerability of RPE Stem Cell-derived RPE (RPESC-RPE) Implantation in Patients with Dry Age-related Macular Degeneration (AMD): Early Low Dose Clinical Outcomes

Validation of a 3D printed smartphone-based lensmeter enhanced by AI for lens power measurements

Consensus Recommendations for Studies of Outflow Facility and Intraocular Pressure Regulation Using Ex Vivo Perfusion Approaches

Innovative imaging techniques to study the entire accommodative apparatus; discovering new accommodative phenomena; testing presbyopia interventions.

Restoration of accommodation by hyaluronic acid (HA) injection

Evaporative Heavy Liquids for Retinal Tamponade

Port Delivery System With Ranibizumab (PDS) in diabetic macular edema (DME): additional primary analysis results of the phase 3 Pagoda trial

Port Delivery System with ranibizumab (PDS) stabilizes retinal nonperfusion and macular leakage: results from Pagoda and Pavilion phase 3 trials in diabetic macular edema (DME) and diabetic retinopathy (DR)

To View More...

You must be signed into an individual account to use this feature.